Among them, the biggest benefit is the biomedical industry. It is necessary to set up a M&A fund with a scale of 10 billion, which is specifically aimed at the merger and reorganization of the biomedical industry! The focus is on local enterprises in Shanghai, especially the biomedicine of listed companies in Shanghai.News:
Many of them announced their reduction in the evening, except for the 11-board Yiming food, others also included.Iii. 11 Linked Board Yiming Food: Shareholders reduced their holdings of 138,200 shares today, and there is a risk of a sharp decline in the short term.News:
Shanghai builds a merger and reorganization head company, and Ning Wang magnifies the move. The bull market still needs to be believed.News:Guoxin Technology: shareholders such as the National Fund intend to reduce their holdings by no more than 3%;
Strategy guide
12-14
Strategy guide 12-14